Fatty acids, not insulin, modulate α1-adrenergic reactivity in dorsal hand veins

Hypertension

Volumn 30, Issue 5, 1997, Pages 1150-1155

  Stepniakowski, Konrad T ^a   Lu, Gang ^a   Miller, Gregory D ^a   Egan, Brent M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Acetylcholine; Adrenoceptors; Fatty acids; Indomethacin; Insulin; Nonesterified

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; FATTY ACID; INDOMETACIN; INSULIN;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CORONARY RISK; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; INSULIN RESPONSE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; VASODILATATION;

EID: 0030696047     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1150     Document Type: Article

References (47)

1. Stern M, Haffner S. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis. 1986;6:123-129.
2. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism of insulin resistance. J Clin Invest. 1990;85: 1844-1852.
3. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
4. O'Hare JA, Minaker KL, Rowe JW, Pallotta JA, Young JB. Effect of insulin on plasma norepinephrine and 3,4-dihydroxyphenylalanine in obese men. Metabolism. 1989;38:322-329.
5. Alexander WD, Oake RJ. The effects of insulin on vascular reactivity to norepinephrine. Diabetes. 1977;26:611-614.
6. Zemel MB, Reddy S, Sowers JR. Insulin attenuation of vasoconstrictor responses to phenylephrine in Zueker lean and obese rats. Am J Hypertens. 1991;4:537-539.
7. Sakai K, Imaizumi T, Masaki H, Takeshita A. Intra-arterial infusion of insulin attenuates vasoreactivity in human forearm. Hypertension. 1993;22:67-73.
8. Feldman RD, Bierbrier GS. Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet. 1993;342:707-709.
9. Egan BM, Shork NJ, Weder AB. Regional hemodynamic abnormalities in overweight men: focus on α-adrenergic vascular responses. Am J Hypertens. 1989;2:428-434.
10. Egan B, Panis R, Hinderliter A, Sehork N, Julius S. Mechanism of increased alpha-adrenergic vasoconstriction in human essential hypertension. J Clin Invest. 1987;80:812-817.
11. Egan BM, Hennes MMI, O'Shaughnessy IM, Stepniakowski KT, Kissebah AH, Goodfriend TL. Obesity hypertension is more closely related to impairment of insulin's fatty acid than glucose lowering action. Hypertension. 1996;27:723-728.
12. Stepniakowski KT, Goodfriend TL, Egan BM. Fatty acids enhance vascular α-adrenergic sensitivity. Hypertension. 1995;25(pt 2): 774-778.
13. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1991;72:96-107.
14. Feldman RD, Hramiak IM, Finegood DT, Behme MT. Parallel regulation of the local vascular and systemic metabolic effects of insulin. J Clin Endocrinol Metab. 1995;80:1556-1559.
15. Aellig WH. A new technique for recording compliance of human hand veins. Br J Clin Pharmacol. 1981;11:237-243.
16. Peuler JD, Johnson BAB, Phare SM, Sowers JR. Sex-specific effects of an insulin secretagogue in stroke-prone hypertensive rats. Hypertension. 1993;22:214-220.
17. Stepniakowski K, Egan BM. Additive effects of obesity and hypertension to limit venous volume. Am J Physiol. 1995;268: R562-R568.
18. Weisenfeld S, Podolsky S, Goldsmith L, Ziff L. Adsorption of insulin to infusion bottles and tubing. Diabetes. 1968;17:766-771.
19. Collier J, Vallance P. Biphasic response to acetylcholine in human veins in vivo: the role of the endothelium. Clin Sci. 1990;78:101-104.
20. Furchgott RF, Zawadzki JT. The obligatory role of endothelial cells in the relaxation of arterial smooth musele cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
21. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.
22. Groop LC, Bonadonna RC, Simonson DC, Petrides AS, Shank M, DeFronzo RA. Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. Am J Physiol. 1992;263:E79-E84.
23. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production and utilization in man. J Clin Invest. 1983;72:1737-1747.
24. 1-adrenoceptors. Am J Physiol. 1996;270:R1340-R1346.
25. Bülow J, Madsen J, Hojgaard L. Reversibility of the effects on local circulation of high lipid concentrations in blood. Scand J Clin Lab Invest. 1990;50:291-296.
26. Neahring JM, Stepniakowski K, Greene AS, Egan BM. Insulin does not reduce forearm α-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension. 1993;22:584-590.
27. Panek RL, Dixon WR, Rutledge CO. Modification of sympathetic neuronal function in the rat tail artery by dietary lipid treatment. J Pharmacol Exp Ther. 1985;233:578-583.
28. 1-adrenoceptor mediated contraction. Am J Physiol. 1991;261:R1465-R1469.
29. Loh HH, Law PY. The role of membrane lipids in receptor mechanisms. Annu Rev Pharmacol Toxicol. 1980;20:201-234.
30. Ruffolo RRJ, Hieble JP. α-Adrenoceptors. Pharmacol Ther. 1994; 61:1-64.
31. 2+ and phospholipids. J Biol Chem. 1986;261:15424-15429.
32. Lu G, Morinelli TA, Meier KE, Rosenzweig SA, Egan BM. Oleic acid-induced mitogenic signaling in vascular smooth muscle cells: a role for protein kinase C. Circ Res. 1996;79:611-618.
33. Lavoie J, Chessex P. The increase in vasomotor tone induced by a parenteral lipid emulsion is linked to an inhibition of prostacyclin production. Free Radic Biol Med. 1994;16:795-799.
34. Adam O, Wolfram G, Zollner N. Prostglandin formation in man during intake of different amounts of linoleic acid in formula diets. Ann Nutr Metab. 1982;26:315-323.
35. Quilley J, Bell-Quilley CP, McGiff JC. Eicosanoids and hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press; 1995:963-982.
36. Grekin RJ, Vollmer AP, Sider RS. Pressor effects of portal venous oleate infusion: a proposed mechanism for obesity hypertension. Hypertension. 1995;26:193-198.
37. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94:1172-1179.
38. Scherrer U, Randin D, Vollenweider P, Wollenweider L, Nicod P. Nitric oxide accounts for insulin's vascular effects in humans. J Clin Invest. 1994;94:2511-2515.
39. Vallance P, Collier J, Moncada S. Nitric oxide synthesised from L-arginine mediates endothelium-dependent dilatation in human veins in vivo. Cardiovasc Res. 1989;23:1053-1057.
40. Arner M, Högestätt ED. Endothelium-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries. Acta Physiol Scand. 1991;142:165-172.
41. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation. 1995;92:2911-2918.
42. Lamontagne D, König A, Bassenge E, Busse R. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol. 1992;20:652-657.
43. Gans ROB, Bilo HJG, v Maarschalkerweerd WWA, Heine RJ, Nauta JJP, Donker AJM. Exogenous insulin augments in healthy volunteers the cardiovascular reactivity to noradrenaline but not to angiotensin II. J Clin Invest. 1991;88:512-518.
44. Baron AD, Brechtel G, Johnson A, Fineberg N, Henry DP, Steinberg HO. Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity: studies in lean and obese men. J Clin Invest. 1994;93:2453-2462.
45. Vollenweider L, Tappy L, Owlya R, Jequier E, Nicod P, Scherrer U. Insulin-induced sympathetic activation and vasodilation in skeletal muscle: effects of insulin resistance in lean subjects. Diabetes. 1995;44:641-645.
46. Nachev C, Collier J, Robinson B. Simplified method for measuring compliance of superficial veins. Cardiovasc Res. 1971;5:147-156.
47. Bevilacqua S, Bonadonna R, Buzzigoli G, Boni C, Ciociaro D, Maccari F, Giorico MA, Ferrannini E. Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism. 1987;36:502-506.